Canary Oncoceutics India Private Limited
About Canary Oncoceutics India Private Limited
Data last updated:
Canary Oncoceutics India Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It was incorporated on 08 December 2023.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U86201TN2023PTC165809.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹20,000. It is led by directors Syed Burhan Ul Haq Bukhari and Syed Anees Ul Islam Bukhari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Rmz Millenia Business Park, Chennai, Tamil Nadu.
Company details
Contact details
Canary Oncoceutics India Private Limited's registered office is in Chennai, Tamil Nadu.
- Registered AddressRmz Millenia Business Park Campus 1A No 143, Dr.M.G.R. Road North Veeranam Salai Sholiganallur, Chennai, Tamil Nadu, India – 600096
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Canary Oncoceutics India Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Canary Oncoceutics India Private Limited, buy the company report.
Board of directors of Canary Oncoceutics India Private Limited
Canary Oncoceutics India has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Syed Burhan Ul Haq Bukhari | Director | 08 Dec 2023 | 2 Years 11 Months | Current |
| Syed Anees Ul Islam Bukhari Also directs: E-Marat Builders Private Limited | Director | 08 Dec 2023 | 2 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Canary Oncoceutics India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Canary Oncoceutics India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Canary Oncoceutics India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Canary Oncoceutics India Private Limited has 4 board changes on record since 2023: 3 appointments and 1 cessation. The latest: Madar Inamul Hasan ceased to be Director on 25 Feb 2025.
Frequently asked questions
Canary Oncoceutics India is an active private limited company based in Chennai, Tamil Nadu, India. It was incorporated on 08 December 2023 (3+ years old) and is registered under CIN U86201TN2023PTC165809.
Canary Oncoceutics India has 2 current directors:
- Syed Burhan Ul Haq Bukhari - Director
- Syed Anees Ul Islam Bukhari - Director
The latest financial statements of Canary Oncoceutics India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Canary Oncoceutics India is U86201TN2023PTC165809. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Canary Oncoceutics India was incorporated on 08 December 2023, making it 3+ years old. It is registered with the Registrar of Companies, Chennai.
Madar Inamul Hasan ceased to be Director on 25 Feb 2025. Madar Inamul Hasan was appointed as Director on 08 Dec 2023. Syed Anees Ul Islam Bukhari was appointed as Director on 08 Dec 2023. Canary Oncoceutics India has 4 board changes on record in total.
The registered office of Canary Oncoceutics India is at Rmz Millenia Business Park Campus 1A No 143, Dr.M.G.R. Road North Veeranam Salai Sholiganallur, Chennai, Tamil Nadu, India – 600096.
Canary Oncoceutics India can be reached at its registered office: Rmz Millenia Business Park Campus 1A No 143, Dr.M.G.R. Road North Veeranam Salai Sholiganallur, Chennai, Tamil Nadu, India – 600096.
Canary Oncoceutics India is registered under the jurisdiction of the Registrar of Companies (ROC), Chennai.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
